← Every company
Humacyte Inc SEC Filings
What Humacyte Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
HUMA overview →Filings on file
81
since Aug 4, 2020
Warning signs
4
latest Jul 31, 2026
Last results
Aug 12, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Sep 28, 2026 | Executive or director change 8-K | Read ↗ |
| Aug 25, 2026 | Delisting 25-NSE | Read ↗ |
| Aug 12, 2026 | Quarterly report 10-Q | Read ↗ |
| Aug 12, 2026 | Results announced 8-K | Read ↗ |
| Jul 31, 2026 | Delisting notice or listing transfer 8-K | Read ↗ |
| Jun 11, 2026 | Material agreement 8-K | Read ↗ |
| Jun 9, 2026 | Shareholder vote 8-K | Read ↗ |
| May 13, 2026 | Quarterly report 10-Q | Read ↗ |
| May 8, 2026 | Delisting notice or listing transfer 8-K | Read ↗ |
| Apr 24, 2026 | Material agreement 8-K | Read ↗ |
| Mar 27, 2026 | Annual report 10-K | Read ↗ |
| Mar 19, 2026 | Material agreement 8-K | Read ↗ |
| Mar 19, 2026 | Results announced 8-K | Read ↗ |
| Dec 16, 2025 | Material agreement 8-K | Read ↗ |
| Dec 15, 2025 | Material agreementNew debtUnregistered share sale 8-K | Read ↗ |
| Dec 15, 2025 | Material agreement 8-K | Read ↗ |
| Nov 26, 2025 | Material agreement 8-K | Read ↗ |
| Nov 12, 2025 | Quarterly report 10-Q | Read ↗ |
| Nov 12, 2025 | Results announced 8-K | Read ↗ |
| Oct 7, 2025 | Material agreement 8-K | Read ↗ |
| Sep 18, 2025 | Material agreementNew debt 8-K | Read ↗ |
| Aug 11, 2025 | Quarterly report 10-Q | Read ↗ |
| Aug 11, 2025 | Results announced 8-K | Read ↗ |
| Jun 11, 2025 | Shareholder vote 8-K | Read ↗ |
| May 13, 2025 | Quarterly report 10-Q | Read ↗ |
| May 13, 2025 | Results announced 8-K | Read ↗ |
| Mar 31, 2025 | Annual report 10-K | Read ↗ |
| Mar 28, 2025 | Results announced 8-K | Read ↗ |
| Mar 26, 2025 | Material agreement 8-K | Read ↗ |
| Nov 14, 2024 | Material agreement 8-K | Read ↗ |
| Nov 8, 2024 | Quarterly report 10-Q | Read ↗ |
| Nov 8, 2024 | Results announced 8-K | Read ↗ |
| Oct 7, 2024 | Material agreement 8-K | Read ↗ |
| Sep 25, 2024 | Material agreement 8-K | Read ↗ |
| Aug 13, 2024 | Quarterly report 10-Q | Read ↗ |
| Aug 13, 2024 | Results announced 8-K | Read ↗ |
| Jun 13, 2024 | Executive or director changeShareholder vote 8-K | Read ↗ |
| May 13, 2024 | Quarterly report 10-Q | Read ↗ |
| May 10, 2024 | Results announced 8-K | Read ↗ |
| Mar 28, 2024 | Annual report 10-K | Read ↗ |
| Mar 22, 2024 | Results announced 8-K | Read ↗ |
| Mar 4, 2024 | Material agreement 8-K | Read ↗ |
| Nov 9, 2023 | Quarterly report 10-Q | Read ↗ |
| Nov 9, 2023 | Results announced 8-K | Read ↗ |
| Aug 14, 2023 | Quarterly report 10-Q | Read ↗ |
| Aug 14, 2023 | Results announced 8-K | Read ↗ |
| Jun 8, 2023 | Shareholder vote 8-K | Read ↗ |
| May 12, 2023 | Quarterly report 10-Q | Read ↗ |
| May 12, 2023 | Results announced 8-K | Read ↗ |
| Mar 24, 2023 | Annual report 10-K | Read ↗ |
| Mar 24, 2023 | Results announced 8-K | Read ↗ |
| Nov 10, 2022 | Quarterly report 10-Q | Read ↗ |
| Nov 10, 2022 | Results announced 8-K | Read ↗ |
| Sep 20, 2022 | Executive or director change 8-K | Read ↗ |
| Aug 12, 2022 | Quarterly report 10-Q | Read ↗ |
| Aug 12, 2022 | Results announced 8-K | Read ↗ |
| Jun 13, 2022 | Shareholder vote 8-K | Read ↗ |
| May 13, 2022 | Quarterly report 10-Q | Read ↗ |
| May 13, 2022 | Results announced 8-K | Read ↗ |
| Mar 29, 2022 | Annual report 10-K | Read ↗ |
| Mar 29, 2022 | Results announced 8-K | Read ↗ |
| Dec 28, 2021 | Executive or director change 8-K/A | Read ↗ |
| Dec 27, 2021 | Executive or director change 8-K | Read ↗ |
| Nov 15, 2021 | Quarterly report 10-Q | Read ↗ |
| Nov 12, 2021 | Results announced 8-K | Read ↗ |
| Sep 17, 2021 | Share offering S-1 | Read ↗ |
| Sep 2, 2021 | Executive or director change 8-K | Read ↗ |
| Aug 30, 2021 | Auditor changeExecutive or director changeAcquisition or sale completedMaterial agreementUnregistered share sale 8-K | Read ↗ |
| Aug 26, 2021 | Delisting 25-NSE | Read ↗ |
| Aug 25, 2021 | Shareholder vote 8-K | Read ↗ |
| Aug 16, 2021 | Quarterly report 10-Q | Read ↗ |
| May 17, 2021 | Quarterly report 10-Q | Read ↗ |
| May 14, 2021 | Annual report 10-K/A | Read ↗ |
| May 13, 2021 | Earlier accounts withdrawn 8-K | Read ↗ |
| Mar 23, 2021 | Merger vote or registration S-4 | Read ↗ |
| Feb 17, 2021 | Material agreementUnregistered share sale 8-K | Read ↗ |
| Feb 16, 2021 | Annual report 10-K | Read ↗ |
| Nov 13, 2020 | Quarterly report 10-Q | Read ↗ |
| Sep 22, 2020 | Material agreementUnregistered share sale 8-K | Read ↗ |
| Sep 18, 2020 | Share offering 424B4 | Read ↗ |
| Aug 4, 2020 | Share offering S-1 | Read ↗ |
Source: Humacyte Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on HUMA
Company overviewEverything on HUMA in one place, with the price.Insider tradingWhat HUMA's own officers and directors buy and sell.Executive payWhat HUMA awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in HUMA.Funds holding itWhich funds and ETFs hold HUMA, and how big a bet.LobbyingWhat HUMA spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on HUMA's account, and who they worked for.PatentsWhat HUMA is filing at the patent office.